Skip to main content
NANOSONICS LIMITED logo

NANOSONICS LIMITED — Investor Relations & Filings

Ticker · NAN ISIN · AU000000NAN9 LEI · 549300XUBCM70BRANN81 ASX Manufacturing
Open in API
Filings indexed 1,048 across all filing types
Latest filing 2024-03-03 Major Shareholding Noti…
Country AU Australia
Listing ASX NAN

About NANOSONICS LIMITED

https://www.nanosonics.com.au

Nanosonics Limited is a medical technology company specializing in the development and commercialization of infection prevention solutions. The company's flagship product, the trophon system, provides automated high-level disinfection (HLD) for ultrasound probes. Utilizing a proprietary hydrogen peroxide mist technology, the trophon device ensures consistent and effective disinfection of both the probe handle and shaft, addressing the risks of cross-contamination in clinical settings. The system is designed to integrate into diagnostic workflows, offering a faster and more environmentally sustainable alternative to traditional manual chemical soaking methods. Nanosonics continues to expand its portfolio with digital traceability tools and audit-ready reporting software to enhance compliance and patient safety across global healthcare facilities.

Recent filings

Filing Released Lang Actions
Change in substantial holding 10 pages 613.6KB
Major Shareholding Notification Classification · 100% confidence The document is titled 'Form 604' and references the Corporations Act 2001, Section 671B, which pertains to notices of change of interests of substantial holders. The content details changes in voting power and relevant interests of a substantial shareholder, including specific share counts and voting percentages. It includes detailed tables of shareholdings and changes, as well as signatures and annexures. This type of filing is a notification of changes in significant share ownership levels, which aligns with the definition of 'Major Shareholding Notification' (Code: MRQ). The document is substantive and not merely an announcement or certification, and it does not fit other categories such as director dealings or capital changes. Therefore, the correct classification is MRQ with high confidence.
2024-03-03 English
Notification regarding unquoted securities - NAN 6 pages 19.1KB
Share Issue/Capital Change Classification · 100% confidence The document is an Appendix 3G form, which is a notification of the issue, conversion, or payment up of unquoted equity securities. It details the issuance of performance rights under an employee incentive scheme, including the number of securities issued, the recipients (including key management personnel), and references to ASX listing rules. The document is a regulatory announcement about a capital change event, specifically the issuance of securities, rather than a full financial report or earnings release. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length and content confirm it is not merely an announcement of a report but a detailed notification of a securities issuance event.
2024-02-28 English
Notification of cessation of securities - NAN 4 pages 14.8KB
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix 3H - Notification of cessation of securities' and details the cessation (lapse) of certain securities (performance rights) for NANOSONICS LIMITED. It provides specific information about the securities that have ceased, the reason for cessation, and the updated issued capital following these changes. The document is a regulatory announcement related to changes in the company's issued securities, specifically the cessation of certain securities. It does not contain financial statements, management discussion, or other report content. The document length is 3772 characters, which is relatively short and focused on a specific regulatory disclosure. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement about securities cessation that does not fit into more specific categories like capital changes (SHA) or director dealings (DIRS).
2024-02-28 English
Change of Director's Interest Notice 4 pages 189.1KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and details changes in securities holdings by a company director, Mr. Michael Kavanagh. It references compliance with ASX Listing Rule 3.19A.2 and provides detailed information about the director's securities holdings before and after the change, including performance rights, service rights, options, and shares. The document is a formal notification of insider share transactions by a director, which aligns with the definition of Director's Dealing filings. There is no financial performance data, earnings information, or management discussion, so it is not an Annual Report, Earnings Release, or Management Report. The document is not a regulatory announcement or report publication but a specific insider transaction report. Therefore, the correct classification is Director's Dealing (DIRS). The document length (6371 characters) supports it being a full notice rather than a brief announcement.
2024-02-28 English
Change of Director's Interest Notice 3 pages 135.4KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings of a company director, including performance rights, service rights, options, and ordinary shares. The document is a formal notification of a director's personal share transactions and interests, which aligns with the definition of Director's Dealing filings. There is no indication that this is a full financial report, audit, or other type of filing. The document length is about 5,068 characters, consistent with a detailed director's dealing notice. Therefore, the correct classification is Director's Dealing (DIRS).
2024-02-28 English
Appendix 4D and Half Year Accounts 29 pages 1.5MB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Nanosonics Limited Half Yearly Report' and references the reporting period ending 31 December 2023, with comparative data for 31 December 2022. It includes detailed financial statements such as the interim consolidated statement of profit or loss, statement of financial position, directors' report, auditor's independence declaration, and directors' declaration. The content is comprehensive and contains actual financial data and analysis for a half-year period. The document also references compliance with Australian Accounting Standard AASB 134 Interim Financial Reporting, which is consistent with interim or quarterly reporting. The length of the document (15,000 characters) and the presence of detailed financial statements confirm it is the report itself, not merely an announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2024
2024-02-25 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.